Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma

Breast and emerging indications for IORT

The advantages of IORT for early breast cancer treatment

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Childhood cancer: The surprising scientific facts

Choosing Wisely in medical oncology

Hemopathy burden at National Cancer Center

To avoid unnecessary second surgery in differentiated thyroid cancer